4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-17-026295
Chief Financial Officer acquired 2,500 shares (grant or award)
- Chief Financial Officer gave up 653 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bonner Michael Chief Financial Officer | 2017-04-07 | Grant or award | +2,500 | $6.45 | $16,125 | 15,300 | D |
| Bonner Michael Chief Financial Officer | 2017-04-07 | Shares withheld for taxes | −653 | $6.45 | $4,212 | 14,647 | D |
Loading xslF345X03/doc4.xml…